amantadine has been researched along with thymalfasin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, K | 1 |
| Shiffman, ML | 1 |
2 review(s) available for amantadine and thymalfasin
| Article | Year |
|---|---|
[Future antiviral therapy for chronic hepatitis C].
Topics: Adjuvants, Immunologic; Amantadine; Animals; Antiviral Agents; Cysteine Endopeptidases; DNA-Directed RNA Polymerases; Drug Therapy, Combination; Enzyme Inhibitors; Hepacivirus; Hepatitis C, Chronic; Humans; Immunization, Passive; IMP Dehydrogenase; Interferons; Nucleosides; Oligonucleotides, Antisense; RNA Helicases; Thymalfasin; Thymosin; Viral Hepatitis Vaccines; Viral Nonstructural Proteins | 2004 |
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.
Topics: Adjuvants, Immunologic; Alcoholism; Amantadine; Antiviral Agents; Black or African American; Clinical Trials as Topic; Counseling; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infusions, Intravenous; Injections, Subcutaneous; Interferons; Liver Cirrhosis; Meta-Analysis as Topic; Oligonucleotides, Antisense; Patient Compliance; Ribavirin; RNA, Viral; Thymalfasin; Thymosin; Time Factors; White People | 2004 |